Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baranca Buijsers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|April 11, 2020
Heparanase in Kidney DiseaseJohan van der Vlag, Baranca Buijsers
Ebiomedicine|August 28, 2020
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patientsBaranca Buijsers, Cansu Yanginlar, Marissa L Maciej-Hulme, et al.
Frontiers in Pharmacology|May 14, 2023
Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathyBaranca Buijsers, Marjolein Garsen, Mark de Graaf, et al.
Frontiers in Immunology|June 27, 2022
Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 - A Proof-of-Concept StudyCarolin Christina Drost, Alexandros Rovas, Irina Osiaevi, et al.
Frontiers in Molecular Biosciences|July 21, 2023
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritisBaranca Buijsers, Marissa Maciej-Hulme, Maaike Jacobs, et al.
Frontiers in Immunology|January 6, 2022
Increased Plasma Heparanase Activity and Endothelial Glycocalyx Degradation in Dengue Patients Is Associated With Plasma LeakageBaranca Buijsers, Fadel Muhammad Garishah, Silvita Fitri Riswari, et al.
Frontiers in Immunology|October 30, 2020
Increased Plasma Heparanase Activity in COVID-19 PatientsBaranca Buijsers, Cansu Yanginlar, Aline de Nooijer, et al.
Ebiomedicine|March 8, 2023
Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuriaMarjolein Garsen, Baranca Buijsers, Marloes Sol, et al.
Cell Reports. Medicine|December 30, 2020
Hydroxychloroquine Inhibits the Trained Innate Immune Response to InterferonsNils Rother, Cansu Yanginlar, Rik G H Lindeboom, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|April 11, 2020
Heparanase in Kidney DiseaseJohan van der Vlag, Baranca Buijsers
Ebiomedicine|August 28, 2020
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patientsBaranca Buijsers, Cansu Yanginlar, Marissa L Maciej-Hulme, et al.
Frontiers in Pharmacology|May 14, 2023
Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathyBaranca Buijsers, Marjolein Garsen, Mark de Graaf, et al.
Frontiers in Immunology|June 27, 2022
Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 - A Proof-of-Concept StudyCarolin Christina Drost, Alexandros Rovas, Irina Osiaevi, et al.
Frontiers in Molecular Biosciences|July 21, 2023
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritisBaranca Buijsers, Marissa Maciej-Hulme, Maaike Jacobs, et al.
Frontiers in Immunology|January 6, 2022
Increased Plasma Heparanase Activity and Endothelial Glycocalyx Degradation in Dengue Patients Is Associated With Plasma LeakageBaranca Buijsers, Fadel Muhammad Garishah, Silvita Fitri Riswari, et al.
Frontiers in Immunology|October 30, 2020
Increased Plasma Heparanase Activity in COVID-19 PatientsBaranca Buijsers, Cansu Yanginlar, Aline de Nooijer, et al.
Ebiomedicine|March 8, 2023
Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuriaMarjolein Garsen, Baranca Buijsers, Marloes Sol, et al.
Cell Reports. Medicine|December 30, 2020
Hydroxychloroquine Inhibits the Trained Innate Immune Response to InterferonsNils Rother, Cansu Yanginlar, Rik G H Lindeboom, et al.
Pageof 1